Rosicki, Rosicki & Associates, P.C., will host its 10th annual fundraising gala on March 28, celebrating a decade of support for the Hunter’s Hope Foundation. The event, titled “Decade of Change,” will be held at the Hyatt Regency in Buffalo, New York. The evening will include various food stations, desserts, and tastings. Proceeds will benefit the Hunter’s Hope Foundation in its fight against Krabbe disease and other leukodystrophies.
Over the years, the Hunter’s Hope Gala has raised thousands of dollars for the foundation’s research and educational programs. The funds have supported the development of treatments and therapies and provided assistance with the financial, medical, and emotional needs of families affected by the illness. Recent donations have helped to increase newborn screening for leukodystrophies and expand research that could also contribute to an understanding of conditions such as stroke and multiple sclerosis.
The gala was founded by Tom and Cynthia Rosicki, who are partners with Rosicki, Rosicki & Associates. Each year, guests from the legal, judicial, and banking communities enjoy a catered meal, silent and Chinese auctions, and presentations about Hunter’s Hope. In 2013, organizers changed the gala’s format and location to provide guests with a firsthand look at where the groundbreaking research takes place. After a tour of the Hunter James Kelly Research Institute at the New York Center of Excellence in Bioinformatics and Life Sciences, guests were treated to a reception.
Jim and Jill Kelly, the founders of Hunter’s Hope, regularly attend the galas to support the fundraising effort and to speak to guests about the foundation’s work. In 2013, Jim Kelly praised Tom and Cynthia Rosicki for their commitment to the organization. He said, “Through their ongoing support, the Rosickis and their guests have had a major part in helping us build the Hunter James Kelly Research Institute.” The institute is named after the Kellys’ son, Hunter, who was diagnosed with Krabbe Leukodystrophy, a fatal nervous system disease.
Blog post 2
[Meta: A study conducted by the Hunter James Kelly Research Institute could lead to a more accurate diagnosis of nervous system disorder.]
Research Findings Could Improve Diagnosis of Krabbe Disease
New findings from a study by the Hunter James Kelly Research Institute may help physicians to predict late-onset Krabbe disease, a rare degenerative disorder that affects the nervous system and provides more timely treatment. While symptoms usually begin appearing in infants, the disease can also manifest itself in teenagers and adults. By utilizing tools to more accurately predict when the symptoms of Krabbe disease could emerge, physicians can better determine when treatment should be administered. Cord blood transplantation, which is currently the only treatment for Krabbe disease, must be given before symptoms develop. Without treatment, Krabbe disease is generally fatal.
Research conducted by the Hunter James Kelly Research Institute has been made possible through supporters such as Rosicki, Rosicki & Associates, P.C., which is preparing to host its 10th Annual Hunter’s Hope Gala on March 28. The annual event, which will feature a dinner, presentations, and auctions, will be held at the Hyatt Regency in Buffalo, N.Y.
The study looked at the medical records of 64 patients registered with the Hunter’s Hope Krabbe World Wide Registry, including their MRI results. Three researchers at the Hunter James Kelly Research Institute found abnormalities in patients’ MRI results that could be tied to the age at which they began to exhibit symptoms.
According to Dr. Patricia Duffner, the author of the study and the founding director of the Hunter James Kelly Research Institute, the findings confirm age-related differences in the MRI scans, particularly as they relate to variations of the disease: adolescent/adult, late onset, and early infantile.
Duffner said that if the research and studies show that MRI abnormalities appear before the onset of symptoms, then the ability to predict late onset of the disease in newborn screenings will be possible.
The Hunter James Kelly Research Institute plans to build on this research in order to further investigate when MRI abnormalities appear in advance of the onset of symptoms. Researchers hope to one day be able to tell parents whose babies screen positive for Krabbe disease if their child is only a carrier of the gene mutation or if he or she will develop symptoms.